Опрос проводится с целью определить, каково жить с гепатитом С (ВГС) и проходить лечение от этого заболевания.

Многие испытания, с которыми сталкиваются люди, живущие гепатитом С, трудно измерить, а иногда даже объяснить. Сложно выразить словами, как гепатит С влияет на такие жизненные аспекты, как уверенность в себе, энергию или настроение, страхи, которые Вы можете испытывать относительно Вашего здоровья или лечения, а также сложности, связанные с раскрытием и обсуждением своего диагноза с близкими или коллегами.

Этот опрос собирает анонимные данные со всего мира для их использования с целью определения новых идей и подходов для медицинских работников (врачей, медсестер и других специалистов), а также широкой общественности – это Ваша возможность поделиться правдой о гепатите С и призвать других присоединиться к борьбе против заболевания.

Оставайтесьвкурсесобытийнаркополитики, подписавшисьна

Добро пожаловать в Исследование Гепатита С

Esta pesquisa busca um maior esclarecimento sobre a realidade vivida por um paciente com Hepatite C e sobre como se dá o tratamento da doença.

Muitos desafios enfrentados pelos pacientes de Hepatite C são difíceis de mensurar e descrever. Pode ser complicado expressar o impacto da Hepatite C em aspectos como a confiança, a disposição e o humor, bem como dividir o receio que pode se sentir ao abordar aspectos relativos à saúde e ao tratamento ou até a experiência do diagnóstico com parentes queridos ou amigos.

Os dados reunidos por esta pesquisa retratam a posicionamentos anônimos de todo o mundo e serão usados para trazer novas abordagens aos profissionais de saúde (médicos, enfermeiros e especialistas) e ao público em geral – é sua oportunidade de compartilhar a realidade que a Hepatite C traz e incentivar outras pessoas a participarem da luta contra esta doença também.

Registe-se para recever as Alertas mensais do IDPC e obter informação sobre questões relacionadas com as políticas de drogas.

Bem-vindo à pesquisa de Hepatite C

L'obiettivo di questa indagine è cercare di capire cosa significhi veramente convivere con l'epatite C (HCV) e sottoporsi ai trattamenti per questa malattia.

Molte delle sfide poste dalla convivenza con l'epatite C sono difficili da misurare e, talvolta, da descrivere. Può essere difficile esprimere le ripercussioni della malattia su aspetti quali la fiducia in se stessi, l'energia o lo stato d'animo, le paure per la propria salute o riguardo il trattamento, così come può esserlo descrivere il momento in cui si è dovuto condividere la propria diagnosi con familiari o colleghi.

I dati anonimi raccolti in questa indagine e provenienti da tutto il mondo saranno utilizzati per offrire nuove conoscenze agli operatori sanitari (medici, infermieri e specialisti) e al pubblico in generale. È un'opportunità per diffondere la verità sull'epatite C ed esortare anche altri ad unirsi alla lotta contro la malattia.

Mantenere up-to-date con gli sviluppi politici droga iscrivendoti al IDPC mensile Alert.

Benvenuti ad HCV Quest

HCV Quest is a global patient survey, investigating the impacts hepatitis C can have on patients’ personal and social life as well as education and work and examining patients’ experience of care.

Through HCV Quest, we are gathering data which will become a powerful tool for patient advocacy and will be used by the Alliance to challenge governments and health policy makers to do more to fight viral hepatitis. The survey can also be printed and saved, so you can share your responses with your doctors and loved ones, helping them to better understand and support your needs.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Global patient survey on the impact of hepatitis C

Pursuant to Resolution AG/RES. 2802 (XLIII-O/13) on the “Promotion and Protection of the Human Rights of People Vulnerable to, Living with or Affected by HIV/AIDS in the Americas,” which was adopted by the General Assembly of the Organization of American States in June 2013, as well as the collaboration agreement signed between the OAS and the Joint United Nations Programme on HIV/AIDS (UNAIDS) in January 2014, both entities are collaborating on the preparation of a 

joint report on “The Social and Human Rights Dimensions of HIV in the Americas.

” The report will serve to inform discussions among Member States and between States and their allies on the challenges that exist to an effective response to HIV and the actions necessary to effectively and sustainably implement integrated care, prevention and support.

The Inter-American Commission of Women (CIM) of the OAS will coordinate the preparation of 

a chapter of this report on “The Human Rights of Women Living with HIV in the Americas

,” by compiling information from the national level through a questionnaire directed to OAS Member States and key civil society organizations, on four issues:

Access to support services and resources;

Inter-sectoral coordination and participation; and

We request your kind collaboration in returning the completed questionnaire no later than 

Questionnaire on the human rights of women living with HIV in the Americas

On November 10 – 11, 2014, a national consultative meeting called “Improving Access to Services for HIV Prevention, Treatment, Care and Support of People who Inject Drugs” was held in Dushanbe, Tajikistan. The meeting was organized by UNAIDS with the participation of the Eurasian Harm Reduction Network (EHRN).

"For Tajikistan, this meeting became a platform for the community of people who use drugs to get extensively involved in a dialogue with the authorities. It’s a rare occasion that the community representatives sit at negotiations with the Deputy Minister of Health, Secretary of the National Coordination Committee on AIDS, leaders of AIDS centers and drug rehabilitation clinics, as well as UN agencies,” said Dasha Ocheret, Deputy Director for Advocacy and Communication, EHRN.

Seeking to take full advantage of this unique opportunity to have a face-to-face dialogue with the authorities on improving the quality of harm reduction programs, EHRN and SPIN Plus, the main EHRN partner organization in Tajikistan, held a two-day preparatory workshop with community representatives. During this workshop, a common position was developed, presentations were coordinated and recommendations for the resolution of the national consultative meeting were prepared.

Well-coordinated cooperation with UNAIDS, as well as careful preparation for and active work at the workshop resulted in tangible achievements that the community of Tajikistan drug users can be proud of.

Face-to-face dialogue between Tajik PWUD community and authorities resulted in tangible achievements

Last Monday, the Danish Prime Minister Helle Thorning-Schmidt visited Mændenes Hjem (Men´s Home), the drug consumption room (DCR) which opened in October 2012 in Copenhagen. Mændenes Hjem has 3,292 registered users and 500-700 daily users.

Since it opened, the DCR has housed 285,000 intakes and 250 drug users have suffered an overdose, but, due to the supervision facillities and the emergency treatment provided by the centre none of them died. In Copenhangen, the number of drug deaths has been reduced by 100 per year.

Drug users from the centre gave a hug to the Prime Minister and thanked her for making this harm reduction proyect possible.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Danish drug consumption room celebrates its second anniversary

Twenty years ago, Ethan Nadelmann left his teaching position at Princeton University to become a full-time advocate for ending the drug war. As the founding executive director of the Drug Policy Alliance (DPA), the largest and most influential organization promoting drug policies grounded in science, compassion, health and human rights, Ethan’s vision and leadership have had a monumental impact on public opinion and changed the course of history.

The Drug Policy Alliance has reformed state and federal laws involving drug sentencing, access to sterile syringes to reduce HIV/AIDS, addiction treatment, prevention of overdose fatalities, and all aspects of marijuana policy. DPA and its lobbying arm, Drug Policy Action, played an instrumental role in securing monumental drug policy reform victories in the recent midterm elections, including marijuana legalization in Oregon, Alaska and Washington, D.C., marijuana decriminalization in New Mexico, medical marijuana in Guam, and groundbreaking criminal justice and sentencing reforms in New Jersey and California.

Ethan Nadelmann's Fiery TED Talk: What has the war on drugs done to the world?

This article was first published by the Foreign Policy Centre, and is adapted from a chapter in AIDS Today: 2014 Edition. You can read the original here.

Before Russia wrested control of the Crimean peninsula in March this year, HIV transmission rates were falling in this region, thanks to life-saving schemes offered to drug users including needle syringe programmes and opioid substitution therapies (OST). But since coming under Russia’s draconian drug laws, these schemes have been closed down, leading to at least 20 deaths already.

Russia’s dangerous stance toward drug users is causing untold harm in the fight against AIDS on the streets of our own cities and towns today. A shadowy world of drug-taking and rampant HIV infection pervades some of the most vulnerable groups in our society, who are stigmatised and marginalised by a state that refuses to take responsibility for their plight.

The facts speak for themselves: nearly 5 million people use illegal drugs in Russia, 1.7 million of whom are opiate users. Almost 60 percent of officially registered HIV cases in 2013 were also people who use drugs. In some cities, HIV prevalence among people who inject drugs is as high as 74 percent. The epidemic is on the rise, with 800,000 people officially registered as HIV positive and many others who do not even know their status.

Tuberculosis has reached epidemic proportions in Russia, now the primary cause of death among people with HIV, and 78 percent of men with both TB and HIV are injecting drug users. The total number of people with the hepatitis C virus who also inject drugs is estimated to be over one million.

Despite this shocking scenario, the state provides no services to stem drug dependency and its related health and social problems. People who use drugs are depicted by state officials as “deviant” and as criminals, and therefore undeserving of equal access to healthcare. The Russian government refuses to adopt even the most mainstream and well-studied approaches to drug treatment, including OST, which is actually illegal. Instead, anti-psychotic drugs that were used against Soviet dissidents are part of the standard regime for treating drug dependency in state facilities, a practise contravening international standards.

Russia’s drug users have a right to needles, methadone, dignity

For the last four decades, the USA has relentlessly expanded the size of our criminal justice system, needlessly throwing away too many lives and wasting trillions of taxpayer dollars. This criminal justice system is unproductive, wasteful, and dominated by racial disparities. Bad policies are made, and bad policies can be changed. The American Civil Liberties Union (ACLU) campaign is called Smart Justice Fair Justice at it is already implementing solutions.

Join the fight against mass incarceration.

Some of the proposals include the following:

Over the last 40 years, we've spent trillions of dollars enforcing senseless drug laws. Drug use has not declined, while millions of people – disproportionately poor people and people of color – have been swept into a net of correctional control that is difficult to escape and derails lives. Many have been arrested just for having a small amount of drugs. Better solutions exist.

The hallmark of a legitimate justice system is fairness. And yet, today in America, hundreds of thousands of people are serving decades-long prison sentences that are far out of proportion to their crimes. The culprit? Extreme sentencing laws and mandatory minimum laws that strip judges of their ability to make the sentence actually fit the crime. It's time to change these laws.

 Some people and corporations – such as private companies that get larger payments from the state the longer they hold someone – have a vested interest in the status quo and are working to thwart smart reforms that could reduce incarceration. We need to incentivize smart and fair practices like keeping people in the community when they don't pose a threat.

 Hundreds of thousands of people are locked up not based on any dangerous behavior, but because they could not pay off a fine or were convicted of a nonviolent drug or property crime. Some behind bars are so frail because of old age or illness that they can barely walk. We need to rethink the costly practice of keeping these people behind bars.

 Problems like mental illness, substance use disorders, and homelessness are more appropriately addressed outside the criminal justice system altogether. Services like drug treatment and affordable housing cost less and can have a better record of success. It's time we got serious about pulling our money out of incarceration and putting it into systems that foster healthy communities.

ACLU launches a campaign to end mass incarceration in USA

在防治艾滋病毒和艾滋病的全球信息是明确的——任何人都不应被抛在后面。英语版本拥有更多信息，请阅读下文。

随时掌握与药物政策发展相关的最新信息。

The global message on tackling HIV and AIDS is clear - no one should be left behind. However, 30 million men and women spend time in prisons every year and are often overlooked in national strategies and global commitments; the time to turn the HIV tide in prison is pressing. Such a response must also include prison staff and should pay special attention to women in prisons.

UNODC Executive Director Yury Fedotov opened on 16 October 2014 in Vienna the Global Consultation on HIV Prevention, Treatment, Care and Support in Prison Settings. The meeting, addressing the HIV needs of the prison population and staff, is part of UNODC's work to ensure that efforts are intensified globally to tackle the large gaps and disparities existing in the HIV response in prisons.

Mr. Fedotov, referring to the urgent necessity to address comprehensively HIV and the broader health needs of staff and prisoners said "Health in prison is a right guaranteed in international law, as well as in international rules, guidelines, declarations and covenants. Prisoners should have access to medical treatment and preventive measures without discrimination on the grounds of their legal situation." He underlined the need to foster and strengthen collaboration and integration among all stakeholders, including ministries of health and other ministries with responsibilities in prisons, as well as civil society and community-based service providers.

关于监狱中对艾滋病充分反应的需要的讨论

伊朗长时间以来一直有世界上最严峻的毒品依赖问题，但是其政府对于毒品战争的态度依旧充斥着矛盾。英语版本拥有更多信息，请阅读下文。

Iran has long had one of the world’s biggest drug dependence problems, but the government’s attitude toward the drug war remains rife with contradiction. Iran has taken drug dependence very seriously, as evidenced both by its extensive and heavy-handed law enforcement efforts and by the resources it puts toward prevention, treatment and harm-reduction programs. However, officials have at times downplayed the extent of the problem, as politicians have sought to paint a positive picture of the state of drug dependence in Iran.

In a June speech, Interior Minister Abdolreza Rahmani Fazli said that Iran was home to 1.35 million addicts, adding that this number put Iran below the overall world dependence rate. By most accounts, however, the levels of dependence in the Islamic Republic are among the highest in the world. Former UNODC head Antonio Maria Costa has said, “Dependence in Iran is ten times what is known in other countries,” that actual Iranian dependence rates are likely much higher than those reported by the government and that drug dependence rates are actually closer to 6 percent. The last comprehensive survey, according to some scientists, was done in 2004, the year before Mahmoud Ahmadinejad was elected president, and it put Iran’s number of addicts at 3.7 million.

Click here to read the full article (restricted access).

News